Alfonso Recordare
Appearances
- DateMay 7, 2023INTRODUCTION: Due to its rarity, anal adenocarcinoma (AA) does not have a standardized staging system. The tumor (T) stage of an adenocarcinoma arising from the anal canal could be based on depth of invasion, as for rectal adenocarcinoma, or on size, as in anal squamous cell carcinoma…
Speakers
Azienda Ospedale Universita PadovaAzienda Ospedale Universita PadovaPresenter
- DateMay 18, 2024BACKGROUND Stage II colorectal cancer should undergo adjuvant therapy only in the presence of risk factors and vascular, lymphatic, and perineural invasion (VELIPI) are risk factors for recurrence after surgery…
Presenter
Speakers
Azienda Ospedale Universita Padova - DateMay 19, 2024BACKGROUND: Adjuvant therapy after rectal cancer surgery is indicated in T4N0 or any T and nodal metastasis and/or risk factors for recurrences…
Speakers
Azienda Ospedale Universita PadovaPresenter